| 1/2 | US=47 / Câncer Bender RP, Osheroff N. DNA topoisomerases as targets for the chemotherapeutic treatment of cancer. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 57-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. TOPOISOMERASES DE DNA; CANCER. TERAPIA; QUIMIOTERAPIA; TOPOISOMERASE II; TOPOISOMERASE IIALFA; TOPOISOMERASE IIBETA; TOPOISOMERASE II POISONS; FARMACOS ANTICANCERIGENOS; GENOTOXICIDADE; LEUCEMIA; DNA SUPERCOILING; LESAO DNA |
| 2/2 | US=92 / Biol/Mol Larsen AK, Skladanowski A. Established cancer therapies: perturbations of cellular functions by topoisomerase II inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 407-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TOPOISOMERASE II; AGENTES ANTICANCERIGENOS; DOXORRUBICINA; ETOPOSIDE; MORTE CELULAR; PARADA DO CRESCIMENTO; APOPTOSE; NECROSE; CATASTRIOHE MITOTICO; INDUZIDA POR DROGAS PSEUDOSENESCENCE; AUTOFAGIA |